ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
General Health & Fitness
Health & Wellness
COVID-19 Infection is not Worse in Men on Testosterone Replacement Therapy
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 188754" data-attributes="member: 3"><p><strong><span style="font-size: 18px">COVID-19 Infection in Men on Testosterone Replacement Therapy</span></strong></p><p></p><p>Abstract</p><p>Men who contract Coronavirus Disease 2019 (COVID-19) appear to have worse clinical outcomes compared to women which raises the possibility of androgen dependent effects. We sought to determine if testosterone replacement therapy (TRT) is associated with worse clinical outcomes. Through a retrospective chart review, we identified 32 men diagnosed with COVID-19 and on TRT. They were propensity score matched to 63 men diagnosed with COVID-19 and not on TRT. Data regarding comorbidities and endpoints such as hospital admission, intensive care unit (ICU) admission, ventilator utilization, thromboembolic events, and death were extracted. Chi-square and Kruskal-Wallis tests examined differences in categorical and continuous variables, respectively. Logistic regression analysis tested the relationship between TRT status and the study endpoints. There were no statistically significant differences between the two groups and TRT was not a predictor of any of the endpoints on multivariate analysis. <strong>These results suggest that TRT is not associated with a worse clinical outcome in men diagnosed with COVID-19.</strong></p><p></p><p><a href="https://www.jsm.jsexmed.org/article/S1743-6095(20)30936-X/fulltext" target="_blank">COVID-19 in Men on Testosterone</a></p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 188754, member: 3"] [B][SIZE=18px]COVID-19 Infection in Men on Testosterone Replacement Therapy[/SIZE][/B] Abstract Men who contract Coronavirus Disease 2019 (COVID-19) appear to have worse clinical outcomes compared to women which raises the possibility of androgen dependent effects. We sought to determine if testosterone replacement therapy (TRT) is associated with worse clinical outcomes. Through a retrospective chart review, we identified 32 men diagnosed with COVID-19 and on TRT. They were propensity score matched to 63 men diagnosed with COVID-19 and not on TRT. Data regarding comorbidities and endpoints such as hospital admission, intensive care unit (ICU) admission, ventilator utilization, thromboembolic events, and death were extracted. Chi-square and Kruskal-Wallis tests examined differences in categorical and continuous variables, respectively. Logistic regression analysis tested the relationship between TRT status and the study endpoints. There were no statistically significant differences between the two groups and TRT was not a predictor of any of the endpoints on multivariate analysis. [B]These results suggest that TRT is not associated with a worse clinical outcome in men diagnosed with COVID-19.[/B] [URL='https://www.jsm.jsexmed.org/article/S1743-6095(20)30936-X/fulltext']COVID-19 in Men on Testosterone[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
General Health & Fitness
Health & Wellness
COVID-19 Infection is not Worse in Men on Testosterone Replacement Therapy
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top